A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response.

Source:http://linkedlifedata.com/resource/pubmed/id/9241074

Cancer 1997 Aug 1 80 3 401-12

Download in:

View as

General Info

PMID
9241074